title: Increase in fibrinolytic activity after erythropoietin therapy.
authors.forename: J
authors.initials: J
authors.lastname: Szewczuk
authors.forename: M
authors.initials: M
authors.lastname: Mazerska
authors.forename: J
authors.initials: J
authors.lastname: Malyszko
authors.forename: M
authors.initials: M
authors.lastname: Kalinowski
authors.forename: M
authors.initials: M
authors.lastname: Mysliwiec
mesh_terms: D000328:Adult; D000368:Aged; D001760:Bleeding Time; D004921:Erythropoietin / Q000009:adverse effects*; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D008875:Middle Aged; D011994:Recombinant Proteins / Q000009:adverse effects
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin